Geotechnical instrumentation sales expert Matt Azzopardi has joined Worldsensing to help the company focus on UK market remote monitoring opportunities.
Bringing sweet tea and juice to the market requires palletizing the cases filled with respective bottles to be palletized for transportation to retail outlets. Due to their perishable nature, they are stored in cold rooms. A customer turned to Motion Controls Robotics Inc (MCRI) from Fremont, OH, to replace an inefficient existing system, in which the vacuum cups and pumps utilized did not cope well with the average temperature in the cold room of 35°F (1.7°C). This caused vacuum cups to become rigid and pumps to not provide enough vacuum to hold cases leading to regular drop downs. A better system had to be found to handle cardboard cases weighing up to 42lbs (19kg).
Intel IOTG
Dane s entire education and professional career has focused on visual communications, first as a sports broadcast & stadium producer, content producer & engineer up to his current role as a visual solutions specialist for Intel s IOT Group. Dane joined Intel in 2016 as a Technical Sales Specialist for Intel s Internet of Things Group, focused on Visual Solutions. Using his expertise in the digital signage and visual communications space, Dane supports Intel s growth in IOT by matching Intel partners & solutions with SI s, end users and beyond to provide guidance and engagement focused on digital signage, collaboration and self-service kiosks, Point-of-Sale, Thin Client & Edge solutions.
Upstream Considerations For Biosimilar Development
By Hunter Malanson, Staff Scientist, Field Applications; Mariana Curcio, Technical Sales Specialist; and Albert Cheong, Associate Director, Services & Product Application, Thermo Fisher Scientific Bioproduction Cell Culture
Many of the early and costly steps of drug development can be eliminated with biosimilars, which offer several advantages to pharmaceutical companies exploring new strategies for increasing their presence in the market. However, essential information regarding aspects of process control, such as upstream control parameters, may be unknown about the innovator drug, resulting in challenges during biosimilar development. Understanding these challenges and creating a strategy to overcome them is critical for ensuring a high chance of success with your biosimilar product.